Role of FDG-PET in the implementation of involved-node radiation therapy for hodgkin lymphoma patients

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 5, 2014, Pages 1047-1052

  Girinsky, Théodore ^a   Aupérin, Anne ^a   Ribrag, Vincent ^a   Elleuch, Manel ^a   Fermé, Christophe ^a   Bonniaud, Guillaume ^a   Ruelle, Claude ^a   Alberini, Jean Louis ^b   Celebic, Aljosa ^a   Edeline, Véronique ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; NUCLEAR MEDICINE; ONCOLOGY; PATIENT MONITORING; QUALITY ASSURANCE; RADIOTHERAPY;

CLINICAL TARGET VOLUMES; CONFIDENCE INTERVAL; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; GROSS TUMOR VOLUME; INVOLVED NODES; METHODS AND MATERIALS; PLANNING CT; RADIATION ONCOLOGISTS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HODGKIN DISEASE; HUMAN; INVOLVED NODE RADIATION THERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION ONCOLOGIST; SENSITIVITY ANALYSIS; TREATMENT PLANNING; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CONFIDENCE INTERVALS; DACARBAZINE; DIAPHRAGM; DOXORUBICIN; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; VINBLASTINE; YOUNG ADULT;

EID: 84904128157     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.04.026     Document Type: Article

References (21)

1. J. Yahalom, and P. Mauch The involved field is back: issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 suppl 1 2002 79 83
2. M.L. De Bruin, J. Sparidans, and M.B. van't Veer et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
3. B.M.P. Aleman, A.W. van den Belt-Dusebout, and W.J. Kiokman et al. Long-term cause-specific mortality of patients treated for Hodgkin disease J Clin Oncol 21 2003 3431 3439
4. T. Girinsky, R. Van der Maazen, and L. Specht et al. on behalf of the EORTC-GELA Lymphoma Group. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines Radiother Oncol 79 2006 270 277
5. T. Girinsky, L. Specht, and M. Ghalibafian et al. on behalf of the EORTC-GELA Lymphoma Group. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
6. K.W. Yeoh, and N.G. Mikhaeel Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy? Int J Radiat Oncol Biol Phys 85 2013 14 20
7. T. Girinsky, M. Ghalibafian, and G. Bonniaud et al. Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85 2007 178 186
8. P. Seam, M.E. Juweid, and B.D. Cheson The role of FDG-PET scans in patients with lymphoma Blood 110 2007 3507 3516
9. B.D. Cheson, S.J. Horning, and B. Coiffier et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored International Working Group J Clin Oncol 17 1999 1244 1253
10. B.D. Cheson, B. Pfistner, and M.E. Juweid et al. Revised response criteria for malignant lymphoma J Clin Oncol 25 2007 579 586
11. M. Meignan, E. Itti, and S. Bardet et al. Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials J Clin Oncol 27 2009 2739 2741
12. A. Le Maitre, M. Hatt, and O. Pradier et al. Impact of the accuracy of automatic tumour functional volume delineation on radiotherapy treatment planning Phys Med Biol 57 2012 5381 5397
13. H. Zaidi, M. Abdoli, and C.L. Fuentes et al. Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma Eur J Nucl Med Mol Imaging 39 2012 881 891
14. J.F. Daisne, N. Sibomana, and A. Bol et al. Tri-dimensional automatic segmentation of FDG-PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother Oncol 69 2003 247 250
15. B.A. Campbel, N. Voss, and T. Pickles et al. Involved nodal radiotherapy as a component of combination therapy for limited stage Hodgkin lymphoma: a question of field size J Clin Oncol 26 2008 5170 5174
16. A.K. Berthelsen, S. Holm, and A. Loft et al. PET-CT with intravenous contrast can be used for PET attenuation correction in cancer patients Eur J Nucl Med Mol Imaging 32 2005 1167 1175
17. 18F]FDG- positron emission tomography coregistration with computed tomography scan for radiation treatment planning of lymphoma and hematologic malignancies Int J Radiat Oncol Biol Phys 81 2011 615 622
18. H. Metwally, F. Courbon, and I. David et al. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition Int J Radiat Oncol Biol Phys 80 2009 793 799
19. A.C. Paulino, J. Margolin, and Z. Dreyer et al. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma Pediatr Blood Cancer 58 2012 860 864
20. M. Hutchings, A. Loft, and M. Hansen et al. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early stage Hodgkin lymphoma Eur J Haematol 78 2007 206 212
21. D.J. Straus Chemotherapy alone for early-stage Hodgkin's lymphoma N Engl J Med 366 2012 470 471